Canada leisurely legalizes pot
Government takes it slow in the first week of sales
VANCOUVER, British Columbia – Canada’s launch of legal marijuana sales may set the stage for a global cannabis revolution, unleashing a wave of highquality medical research that could bolster pot’s reputation as a healthier alternative to alcohol and tobacco and fuel an economic boom across the USA.
Starting Wednesday, Canada becomes the highest-profile country to not only decriminalize cannabis possession and use but also tax, regulate and monitor its growth, distribution and sale.
“They know they are the global leaders if they get it right. And they are making this a priority from the top down,” said April Pride of Van der Pop, a Seattle-based women-focused cannabis lifestyle brand operating in the USA and Canada.
Canada’s national approach means pot businesses can use banks, trade stocks and sponsor peer-reviewed medical studies like any other pharmaceutical operation. It’s a far cry from the piecemeal approach taken in the USA, where cannabis entrepreneurs worry the Justice Department may swoop in if the political winds shift. Though a majority of states have adopted some form of legal weed, marijuana remains illegal at the federal level in the USA.
American-based cannabis firms welcome Canadian legalization, in part because it’s a new market for them and in part because it could provide further support for legalization efforts in the USA and across the globe.
Supplies are likely to be scarce at first, largely because the country’s provinces haven’t finished the permitting process for privately owned stores. This week will see only a relative handful of stores open across Canada, and many of those will be government-run.
Users will be allowed to buy online and have products shipped to their homes, a recognition of how spread out Canada’s approximately 37 million residents are. For comparison, California has about 39 million residents living in a state 25 times smaller than Canada.
Uruguay is the only other country that has legalized marijuana, and Canada’s status as a member of the powerful Group of 7 economic alliance, which includes the USA, France and Japan, gives its legalization added emphasis.
“The big difference – and it is a critical difference – is the blessing provincial governments have received from their federal government,” said Steve Hawkins, executive director of the Marijuana Policy Project, one of the biggest pro-legalization groups in the USA. “Hopefully, Congress will take notice quickly, and that competitive American spirit will kick in sooner rather than later.”
International alcohol and tobacco companies are investigating or partnering with Canadian cannabis companies, including Molson Coors and Marlboro maker Altria. Those moves reflect a more traditional way of thinking, that marijuana use is primarily for afterwork or social relaxation, said Marc Lustig, chairman and CEO of the crossborder CannaRoyalty, a publicly traded marijuana company. He said there’s a potentially much larger market for cannabis as a medical product.
In the USA, legalization critics said marijuana enthusiasts should wait for evidence-based research before relaxing cannabis prohibition. That’s created a Catch-22 situation in which American researchers are tightly limited in how they can investigate marijuana because it’s illegal.
“If it turns out that true research done by qualified clinicians proves that cannabis can treat anxiety better than Xanax or relieves pain better than Advil, think about the implications of that,” Lustig said. “People have largely fo- cused on this being as a recreational product, (but) that’s where this market could go haywire and just blow the top off of this being seen as just an alcohol or tobacco replacement product.”
Critics said that’s precisely the problem with the kind of marijuana legalization Canada is unveiling: It’s a market, with large corporations rushing to commercialize, capitalize and encourage users’ habits.
The U.S.-based anti-legalization group Smart Approaches to Marijuana will launch an effort Wednesday to track any negative impacts of legalization in Canada. The group pointed out that legalizing pot puts the country at odds with international drug control treaties and risks creating another Big Tobacco industry.
SAM’s executive director, Kevin Sabet, said he’s confident Canadians will reconsider once they understand how legalization can increase dangers from drugged driving, youth use and overall increased consumption of an intoxicant. The group instead supports decreased criminal prosecution, along with improved drug-treatment options for heavy users.
“As more Canadians feel the negative effects – secondhand smoke, workplace accidents, car crashes, declining school performance, loss of productivity and other issues – I am confident the policy will be reversed in time,” Sabet said.
Those concerns are nothing new for Canada’s marijuana enthusiasts who say it’s about time governments bowed to the reality of widespread marijuana use and the demand for alternatives to alcohol and opiates. To help head off concerns, marijuana-infused foods known as edibles, which have accidentally poisoned children across the USA, will remain temporarily banned while Canadian researchers examine their effects.
Though excitement is building toward Wednesday’s start of legal sales, in true Canadian fashion, people are simultaneously tempering expectations.
“As much excitement as there is for my mother to smoke her first joint, the marketplace will not be an experience that matches the excitement level,” Lustig said. “It will take months to roll out.”